The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have

Takashi Kanou1, Chitose Oneyama, Kunimitsu Kawahara

  • 1Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University. 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.

Insights

Csk-binding protein (Cbp) downregulation promotes non-small cell lung cancer (NSCLC) malignancy by enabling c-Src activation. Restoring Cbp suppresses tumor growth, invasion, and metastasis, highlighting Cbp as a potential therapeutic target for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The tyrosine kinase c-Src is frequently upregulated in human cancers, contributing to malignancy.
  • The precise mechanisms regulating c-Src upregulation in cancer remain incompletely understood.
  • Csk-binding protein (Cbp; PAG1) has been implicated in controlling c-Src-induced cell transformation.

Purpose of the Study:

  • To investigate the in vivo role of Csk-binding protein (Cbp) in non-small cell lung cancer (NSCLC).
  • To determine the functional impact of Cbp expression on NSCLC cell behavior and tumor progression.
  • To elucidate the molecular mechanisms by which Cbp influences c-Src activity in lung cancer.

Main Methods:

  • Analysis of Cbp expression levels in human NSCLC cell lines and tissues.
  • Ectopic expression of Cbp in NSCLC cell lines with varying c-Src activity.
  • Assessment of anchorage-independent growth, tumor formation in nude mice, in vitro invasion, and in vivo metastasis.
  • Investigation of c-Src kinase activity and recruitment of Csk to lipid rafts upon Cbp expression.
  • Correlation analysis between Cbp expression and lymph node metastasis in human lung cancer patients.

Main Results:

  • Cbp expression was markedly downregulated in human NSCLC cells.
  • Ectopic Cbp expression suppressed anchorage-independent growth in NSCLC cells with upregulated c-Src.
  • Cbp expression reduced c-Src kinase activity by facilitating the recruitment of c-Src and Csk to lipid rafts.
  • Cbp expression attenuated tumor formation, invasion, and metastasis in preclinical models.
  • A significant inverse correlation was observed between Cbp levels and lymph node metastasis in human lung cancers.

Conclusions:

  • Cbp downregulation is associated with enhanced malignancy in NSCLC.
  • Cbp plays a critical role in Csk-mediated inactivation of c-Src.
  • Cbp functions as a tumor suppressor by inhibiting c-Src-driven oncogenesis in NSCLC.
  • Cbp represents a potential therapeutic target for managing NSCLC characterized by c-Src upregulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...